ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

Major Changes Being Considered By NCI For FCRA

April 14, 1978

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000